Core Viewpoint - The article highlights the recent surge in institutional research and investment interest in sectors such as brain-computer interfaces, commercial aerospace, and digital currency, driven by market trends and new regulatory frameworks [2][15]. Group 1: Brain-Computer Interface (BCI) - The brain-computer interface concept is currently a major market hotspot, with the Wind BCI index rising approximately 20% in the past week [6]. - Companies like Dineike have transitioned brainwave interaction technology from theoretical research to practical applications, indicating significant potential for future growth in various fields [4]. - Dineike has completed trial production of products like smart sleep devices and has submitted applications for medical device registration [6]. - Entropy Technology held three institutional research sessions, attracting 132 institutions, and plans to launch a prototype of its brain-machine business by March 2026 [6][8]. - The company emphasizes that initial efforts will focus on marketing and brand promotion, with uncertain short-term revenue impact [8]. Group 2: Commercial Aerospace - The commercial aerospace sector remains highly active, with the Wind commercial aerospace index also increasing by about 20% over the past week [10]. - Companies like Superjet have engaged in multiple institutional research sessions, indicating a strong interest from over a hundred institutions [10]. - Superjet specializes in manufacturing structural components for commercial rockets, which account for over 25% of the cost of mainstream commercial rockets [12]. - The company is expanding its client base and has made substantial progress in securing new orders [12]. - However, companies in this sector have cautioned about risks related to policy direction, technological breakthroughs, and market demand [14]. Group 3: Digital Currency - The People's Bank of China has introduced a new action plan to enhance the digital renminbi management and infrastructure, set to be implemented on January 1, 2026 [15]. - The policy marks a shift in the positioning of digital renminbi from a cash-like status to a broader monetary category, potentially increasing its application scenarios [15]. - Tianyang Technology believes that banks will need to undertake significant IT system upgrades to accommodate the new digital renminbi features [18]. - Future developments to watch include the issuance of supporting regulations and pilot programs for the digital renminbi, which could signal substantial promotional efforts beyond small retail scenarios [20].

Group 1 - The core viewpoint of the report is that the spring market rally is expected to favor technology growth and certain cyclical industries, suggesting a focus on these sectors in the short term [1] - The report highlights commercial aerospace and brain-computer interfaces as potential main themes for investment during the spring market rally [1] - The commercial aerospace sector is projected to have significant growth potential, with the space economy expected to reach a scale of $1.8 trillion by 2035, driven by policy support and global industry trends [1] - The brain-computer interface market is also anticipated to expand continuously, supported by strong policy backing [1]

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing significant market attention and investment opportunities due to advancements in technology and strong policy support, with expectations for rapid growth in the coming years [1][12][19] Group 1: Market Performance and Drivers - The BCI sector saw a collective surge in stock prices, with average daily gains exceeding 12% and nearly 20 stocks hitting the 20% limit up, driven by announcements from companies like Neuralink and Merge Labs [1][12] - The market's optimism is fueled by the expectation of commercial production of BCI devices starting in 2026, marking a critical transition from clinical trials to commercial viability [11][12] - Recent policies from the Chinese government, including the "14th Five-Year Plan," have positioned BCI as a key future industry, further enhancing investor confidence [12][13] Group 2: Development Stage and Challenges - The BCI industry is currently at a pivotal stage of commercial transformation, transitioning from clinical validation to early commercialization, with significant technological breakthroughs [14][15] - Major challenges for mass production include ensuring biocompatibility, ethical regulations, and cost control, particularly for invasive BCI devices [15][16] - The industry is expected to see applications primarily in medical rehabilitation and treatment of neurological disorders, with potential expansion into consumer electronics and industrial applications in the long term [17][18] Group 3: Future Applications and Strategic Value - As technology matures, BCI applications are anticipated to expand into various fields, including consumer electronics and industrial monitoring, alongside continued focus on medical applications [17][18] - The BCI sector is recognized for its long-term strategic value, supported by strong policy backing and capital investment, although it remains in the early stages of development [19][20] - Investors are encouraged to adopt a long-term perspective, considering diversified investment strategies to mitigate risks associated with market volatility [20][21]

【导读】基金经理解读脑机接口投资机会 中国基金报记者 方丽 孙晓辉 随着产业化进程按下加速键，脑机接口板块近期被推上市场的风口浪尖。 2026年开年，脑机接口概念股集体狂欢，板块单个交易日平均涨幅一度超过12%，近20只个股收获20%涨停。这场资本盛宴的引爆点来 自马斯克的Neuralink公司 将 在2026年开始大规模生产脑机接口设备，以及OpenAI的CEO Sam Altman支持的Merge Labs也在分拆独 立，专注于超声波脑机接口技术等。 脑机接口行情持续性如何？当前处于什么发展阶段？未来应用领域会向哪些方向渗透？投资者如何掘金？ 为此，中国基金报记者采访了 嘉实基金大科技研究总监、基金经理王贵重，永赢医疗器械ETF基金经理储可凡，长城消费增值基金经理龙 宇飞，诺德基金基金经理朱明睿 。 上述基金经理认为，近期政策的强力支持和产业进展的超预期产生共振，支撑板块上涨。在政策与技术双轮驱动下，脑机接口作为"人工智 能+"的 一 部分，已经从硬件创新的第一阶段、媒介迁移的第二阶段演进到商业模式变革的第三阶段，即将进入高速增长期，其市场具有广 阔的投资前景。随着政策与资本加速构建产业生态，行业具备长期 ...

Group 1 - Musk predicts that general artificial intelligence (AGI) will arrive by 2026, and robots will surpass human surgeons in 3 to 4 years [1][3] - The development of humanoid robots like Optimus is expected to significantly impact the medical field, potentially leading to the obsolescence of human surgeons [1][3] - The concept of AGI refers to AI systems that possess cognitive abilities comparable to or exceeding those of humans, capable of learning, reasoning, and adapting [3] Group 2 - Neuralink, Musk's brain-machine interface company, is already using robots for "brain insertion" surgeries, with over 10,000 patients reportedly waiting for procedures [4] - The surgical robots have improved efficiency, reducing the time to implant a single electrode from 17 seconds to 1.5 seconds, with the goal of making surgeries quick enough to be completed during a lunch break [4][5] - The technology involves a complex visual system that integrates multiple microscopes and optical coherence tomography (OCT) for real-time tracking of brain tissue [5] Group 3 - Experts express skepticism about the feasibility of fully autonomous surgical robots within the next five years, emphasizing the need for human oversight in current operations [7][8] - While robots can enhance surgical efficiency, the complete replacement of human surgeons is not anticipated in the short term, as the technology still relies on human intervention [7][8] - The market for surgical robots is currently dominated by a few leading companies, with significant investment activity noted in the sector [9][10] Group 4 - The domestic surgical robot market is experiencing rapid growth, with substantial financing and IPO activities indicating investor confidence [9][10] - The market for vascular interventional surgical robots is projected to reach 5.824 billion RMB by 2030, with a compound annual growth rate of 90% [12] - Recent regulatory developments are expected to establish a pricing framework for surgical robot-assisted treatments, which could accelerate their adoption in clinical settings [11][12]

Investment Rating - The industry rating is "Outperform the Market," indicating that the overall return of the industry is expected to exceed the market benchmark index by more than 5% in the next 6 months [14]. Core Insights - Strong Brain Technology has completed approximately 2 billion yuan in financing, making it the second-largest in the global brain-computer interface (BCI) sector, following Neuralink. This financing round was led by IDG Capital and Huaden International, with participation from industry chain companies, enabling product scaling through a "capital + manufacturing" model [4][6]. - The company focuses on non-invasive technology, with its core product, the "Super Sensor," capable of capturing brain electrical signals without the need for surgery. This technology has already assisted individuals with disabilities in performing complex movements, with plans to help one million disabled individuals regain mobility and assist ten million patients in rehabilitation over the next 5-10 years [4][6]. - Neuralink, a key player in the BCI field, is set to initiate large-scale production of BCI devices in 2026 and is advancing fully automated surgical solutions. This invasive technology complements Strong Brain Technology's non-invasive approach, collectively driving the commercialization of global BCI technology [5][6]. - The global BCI market is projected to grow rapidly, with an estimated market size of approximately 2.62 billion USD in 2024, expected to reach 2.94 billion USD in 2025, and potentially grow to 12.4 billion USD by 2034, reflecting a compound annual growth rate (CAGR) of 17.35% over the next decade. In China, the BCI market is anticipated to reach 3.2 billion yuan in 2024 and 6.14 billion yuan by 2028 [6]. Summary by Sections Financing and Market Position - Strong Brain Technology has secured around 2 billion yuan in financing, ranking second globally in the BCI sector, just behind Neuralink [4]. - The financing round was led by IDG Capital and Huaden International, with contributions from various industry chain companies [4]. Technology and Product Development - The company's non-invasive "Super Sensor" technology captures brain signals without surgery, aiding individuals with disabilities [4]. - Plans are in place to assist one million disabled individuals and ten million patients in rehabilitation over the next 5-10 years [4]. Market Growth Projections - The global BCI market is expected to grow from 2.62 billion USD in 2024 to 12.4 billion USD by 2034, with a CAGR of 17.35% [6]. - The Chinese BCI market is projected to grow from 3.2 billion yuan in 2024 to 6.14 billion yuan by 2028 [6].

Core Viewpoint - The article highlights a significant milestone in China's brain-computer interface (BCI) field, showcasing the successful completion of the first human clinical trial of a fully implanted, wireless, and fully functional BCI system, marking a shift from "catching up" to "keeping pace" and even "leading" in this core technology area [2][4]. Group 1: Clinical Trial and Patient Experience - The first patient, a 28-year-old man paralyzed for eight years due to a car accident, demonstrated remarkable recovery, using his thoughts to browse websites and play video games, showcasing the system's capabilities [3][6]. - The BCI system, developed by Fudan University Huashan Hospital and NeuroXess, allows patients to control smart home devices and regain autonomy in daily activities, significantly improving their quality of life [4][6]. Group 2: Technical Features of the BCI System - The BCI system is characterized by being fully implanted, wireless, and fully functional. It eliminates external cables, reducing infection risks and enhancing the patient's dignity [9]. - The system integrates wireless power and data transmission, allowing patients to interact in real-time without external devices, providing true "wireless freedom" [9]. - It features a complete system that includes brain signal acquisition, processing, and wireless energy transmission, demonstrating strong openness and extensibility through its proprietary operating system, XessOs [10][13]. Group 3: Comparison with International Competitors - The Chinese BCI solution differs from Elon Musk's Neuralink by separating the battery from the main control unit, placing it in the chest area to enhance safety and reduce heat risks to the brain [14][15]. - The surgical procedure for the Chinese BCI is more accessible, utilizing established techniques that can be performed by many neurosurgeons, facilitating broader clinical application [17]. Group 4: Future Aspirations and Innovations - The ultimate vision for BCI technology includes advancements in language decoding and consciousness interaction, with the Chinese team already achieving real-time Chinese language decoding at double the speed of normal speech [19][20]. - The concept of a "brain internet" is being explored, allowing patients to communicate through digital avatars, indicating a significant leap towards human-machine symbiosis [20][23]. Group 5: Ethical Considerations and Challenges - Experts emphasize the importance of data quality and ethical boundaries in BCI development, with a focus on high-quality brain signal data for effective model training [22]. - The article concludes with a vision of BCI technology not just as a medical device but as a key to unlocking human potential and extending cognitive and existential boundaries [23][24].

Core Insights - The article discusses the establishment of pricing for brain-computer interface (BCI) medical services in various provinces in China, highlighting the integration of these services into the healthcare system and the support from government policies [4][5][10]. Pricing and Policy Developments - The Sichuan Provincial Medical Insurance Bureau has set a maximum price for BCI services, effective from April 30, 2026, with different pricing based on hospital levels for invasive procedures [4]. - Other provinces, including Hubei, Zhejiang, and Jiangsu, have also established pricing for BCI services, with costs for invasive procedures ranging from approximately 6,000 to 6,600 yuan per procedure [5][6][7]. - The pricing structure includes insertion fees, removal fees, and adaptation fees, with some provinces incorporating non-invasive adaptation fees into insurance coverage [5][8]. Government Support and Strategic Planning - The Chinese government has outlined a strategic plan to support the BCI industry through policies that focus on planning, payment, and standards, aiming for significant advancements by 2030 [10][11]. - Multiple provinces have released action plans to promote BCI innovation and commercialization, with specific targets for clinical applications and production [11]. Technological Advancements and Market Potential - The article notes that while invasive BCI products are still in clinical trials, non-invasive products have begun to enter the market, indicating a growing application space [12]. - The industry is at a critical juncture where technological breakthroughs are expected to lead to commercial viability, supported by favorable policies and anticipated production from companies like Neuralink [15][17]. Investment Opportunities - Analysts suggest focusing on key segments of the BCI industry, including hardware suppliers, companies with core patents, and those involved in rehabilitation and industrial applications [15][16]. - Specific companies are highlighted as potential beneficiaries of the BCI market growth, including Aipeng Medical, Lepu Medical, and Xiangyu Medical, among others [16].

经济观察报 记者 钱玉娟 1月9日，经济观察报记者从浙江强脑科技有限公司（下称"强脑科技"）处确认，其已完成约20亿元人民币的新一轮融资。这一数额不仅刷新了非侵入式BCI 领域的单笔融资纪录，更使其成为继埃隆·马斯克旗下的Neuralink之后，全球融资规模第二大的脑机接口企业。 强脑科技相关人员表示，此次募集资金将用于全力加速脑机接口核心技术研发、极限工程突破、产品规模化、量产落地。 和以往多是财务投资机构不同，强脑科技在这一轮融资中选择和产业链上下游企业"牵手"。投资方不仅涵盖了IDG资本、华登国际等财务与半导体投资机 构，还引入了蓝思科技、领益智造、韦尔股份等"果链"核心制造巨头，还有来自润泽科技、华住集团、好未来集团等产业资本，以及中国香港、美国顶级家 族办公室等机构投资。 其中，蓝思科技承接了强脑科技核心硬件模组量产相关工序，领益智造也与强脑科技签订战略合作协议。 参投强脑科技的一名资方管理层人士向经济观察报透露，强脑科技正在加速推进资本化动作，即将递表上市。对此，强脑科技相关人员表示，公司还没有具 体上市时间表。 1月8日，工信部、国家发改委、国资委等八部委联合印发的《"人工智能+制造"专项行动实 ...

Core Viewpoint - The brain-computer interface (BCI) sector is expected to experience a significant wave of financing in 2026, driven by advancements in technology and supportive government policies [5][6][9]. Group 1: Market Dynamics - Non-invasive BCI company "Qiangnao Technology" recently completed a financing round of 2 billion yuan, igniting interest in BCI concept stocks [6]. - The BCI sector has seen a strong market response, with companies like Innovation Medical, Nanjing Panda, and Yanshan Technology experiencing stock price surges [7]. - Elon Musk's announcement regarding Neuralink's plans for large-scale production of BCI devices by 2026 has been a major catalyst for the current market enthusiasm [7]. Group 2: Investment Landscape - Major venture capital firms such as Sequoia China, IDG, and Baidu Ventures have invested in various BCI companies, indicating a broadening interest beyond just medical applications to technology and consumer sectors [9]. - The BCI market is transitioning from primarily medical investments to include technology and consumer-focused investments, particularly in consumer healthcare applications [9]. Group 3: Non-Invasive BCI Insights - Non-invasive BCI technology has a wide range of applications, including sleep monitoring, attention tracking, and treatment for mental health disorders, but has faced challenges due to high user education costs and product homogeneity [10][12]. - The technology has limitations in signal quality, as non-invasive methods like EEG struggle with signal clarity and resolution [10]. - Companies are shifting focus from pure brain control to developing smart prosthetics and other applications that utilize muscle signals and AI algorithms for better intent recognition [11]. Group 4: Invasive BCI Developments - Invasive BCI companies are navigating significant challenges, including safety, signal stability, and regulatory compliance, but have still managed to secure funding during market downturns [13]. - The evaluation of BCI companies has shifted from focusing solely on technical capabilities to assessing their overall operational capabilities and clinical trial progress [13]. - Notable invasive BCI companies include Borui Kang, which is pursuing a listing on the Science and Technology Innovation Board, and has reported successful clinical trials with significant patient improvements [14]. Group 5: Key Players and Innovations - Borui Kang has developed a semi-invasive BCI system that has shown promising results in clinical trials, achieving significant improvements in patient functionality [14]. - Ladder Medical focuses on ultra-flexible neural electrode technology and has successfully conducted clinical trials for spinal cord injury patients [15][16]. - Brain Tiger Technology, which aims to compete with Neuralink, utilizes silk protein for its electrodes, enhancing biocompatibility and reducing long-term damage [17]. Group 6: Future Outlook - The year 2026 is anticipated to be a pivotal moment for the BCI industry, with advancements in technology and regulatory support paving the way for broader adoption [22]. - The introduction of independent billing for BCI services by the National Healthcare Security Administration in 2025 reflects a commitment to supporting the industry's growth [22]. - Companies that establish a strong foothold in the BCI sector are likely to gain significant influence over future technologies, products, and standards [23].